AL, C., CJ, A., B, J., LM, B., DC, S., K, S., . . . H, C. (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: A prospective phase 1 trial. Journal of neuro-oncology, 148(3), 577. https://doi.org/10.1007/s11060-020-03551-3
Chicago Style (17th ed.) CitationAL, Cohen, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, and Colman H. "Repeat Radiation with Bevacizumab and Minocycline in Bevacizumab-refractory High Grade Gliomas: A Prospective Phase 1 Trial." Journal of Neuro-oncology 148, no. 3 (2020): 577. https://doi.org/10.1007/s11060-020-03551-3.
MLA (9th ed.) CitationAL, Cohen, et al. "Repeat Radiation with Bevacizumab and Minocycline in Bevacizumab-refractory High Grade Gliomas: A Prospective Phase 1 Trial." Journal of Neuro-oncology, vol. 148, no. 3, 2020, p. 577, https://doi.org/10.1007/s11060-020-03551-3.